Search

everythinglearnresearchcommunity

for

Search:↓

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.